During the past decade, MHAT Sveta Karidad conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MHAT Sveta Karidad" are "Atrial Fibrillation" (1 trials), "Chronic Kidney Disease" (1 trials), "Diabetic Retinopathy" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "MHAT Sveta Karidad" in a lesser frequency.

Most popular intervention types in "MHAT Sveta Karidad" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Finerenone (BAY94-8862)" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "MHAT Sveta Karidad" are 4 trials for "All" genders.

Currently, there are NaN active trials in "MHAT Sveta Karidad". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MHAT Sveta Karidad, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MHAT Sveta Karidad, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".